A method for the manufacture of citalopram characterised in(i) reaction of 1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-halophtalane with activated magnesium to form the Grignard reagent [3-[1-(4-fluorophenyl)-1,3 dihydro-isobenzofuran-1-yl]propyl]dimethylamine 5-magnesium halide followed by (ii) reaction of [3-[1-(4-fluorophenyl)-1,3 dihydro-isobenzofuran-1-yl]propyl]dimethylamine 5-magnesium halide with a compound containing a -CN group bound to a leaving group to form citalopram.
申请公布号
WO0204435(A1)
申请公布日期
2002.01.17
申请号
WO2001DK00481
申请日期
2001.07.06
申请人
H. LUNDBECK A/S;NICOLE, ANDREA;BOLZONELLA, EVA;CASTELLIN, ANDREA